{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:55Z","timestamp":1791425995333,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Center for HIV\/AIDS Vaccine Immunology-Immunogen Discovery"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jviromet.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T21:45:18Z","timestamp":1504215918000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120"],"prefix":"10.1016","volume":"249","author":[{"given":"Jae-Sung","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Pritchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Mao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilton B","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bonsignori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Vandergrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2017.08.012_bib0005","doi-asserted-by":"crossref","first-page":"e41144","DOI":"10.1371\/journal.pone.0041144","article-title":"Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140","volume":"7","author":"Arias","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pro.757","article-title":"Signal peptidase I: cleaving the way to mature proteins","volume":"21","author":"Auclair","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"Bonaldo","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0030","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0035","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0040","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature18296","article-title":"The Brazilian Zika virus strain causes birth defects in experimental models","volume":"534","author":"Cugola","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0050","first-page":"601","article-title":"Zika virus in the Americas?Yet another arbovirus threat the new england","volume":"374","author":"Fauci","year":"2016","journal-title":"J. Med."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0055","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"Franco","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2009.07.041","article-title":"Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins","volume":"394","author":"Gao","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0075","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nbt.2197","article-title":"B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study","volume":"30","author":"Haynes","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0085","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2016.04.017","article-title":"Zika virus disrupts neural progenitor development and leads to microcephaly in mice","volume":"19","author":"Li","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0100","series-title":"Flaviviridae: The Viruses and Their Replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0105","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0110","doi-asserted-by":"crossref","first-page":"e54434","DOI":"10.1371\/journal.pone.0054434","article-title":"Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques","volume":"8","author":"Martins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0115","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1128\/JVI.00601-14","article-title":"Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239","volume":"88","author":"Martins","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0120","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0135","series-title":"Current Protocols in Immunology","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2005"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/35073500","article-title":"Challenges and opportunities for development of an AIDS vaccine","volume":"410","author":"Nabel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/COH.0b013e328363d389","article-title":"Development of replication-competent viral vectors for HIV vaccine delivery","volume":"8","author":"Parks","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0150","first-page":"741","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology Nature reviews","volume":"9","author":"Pulendran","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0155","series-title":"Molecular Cloning: a Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0160","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies","volume":"84","author":"Seaman","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0165","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.156.4.1504","article-title":"Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella","volume":"156","author":"VanCott","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2017.08.012_bib0170","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2017.08.012_bib0175","doi-asserted-by":"crossref","first-page":"336ra62","DOI":"10.1126\/scitranslmed.aaf0618","article-title":"Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages","volume":"8","author":"Zhang","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"-453","key":"10.1016\/j.jviromet.2017.08.012_bib0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virol.2014.01.017","article-title":"Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment","volume":"452","author":"de Santana","year":"2014","journal-title":"Virology"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093417304147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093417304147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T10:34:29Z","timestamp":1692959669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093417304147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"alternative-id":["S0166093417304147"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2017.08.012","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}